Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion.

Autor:	Pérez-Grande R; Departamento de Microbiología, Hospital Universitario, 37007 Salamanca, Spain., Gutiérrez-Zufiaurre N, Muñoz-Criado S, Blázquez de Castro AM, Vázquez López L, González San Martín F, García Rodríguez JA, Muñoz Bellido JL
Jazyk:	angličtina
Zdroj:	Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2009 May; Vol. 64 (1), pp. 80-2. Date of Electronic Publication: 2009 Mar 21.
DOI:	10.1016/j.diagmicrobio.2009.01.007
Abstrakt:	Hepatitis B reactivation in hepatitis B surface antigen (HBsAg)-negative and anti-HBsAg antibodies-positive patients is an infrequent complication of chemotherapy, usually with fatal evolution. Here we report an HBsAg-negative patient with a myelodysplastic syndrome, who developed hepatitis B reactivation after chemotherapy and evolved favorably after lamivudine treatment, allowing seroconversion.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect